Make sure to check out @doloromics talk by Senior Scientist, Dale George, this Monday at 9:30 during #SfN2023! You’ll get a glimpse of how we’re using technologies developed by @UltimaGenomics, @AtlasXomics, and @LatchBio among others to further drug development for chronic pain!
Congratulations to @CalvinUong for winning a #ABRCMS2022 poster presentation award in Neuroscience! Congratulations to all of my students who attended their first conference at @ABRCMS and for the opportunity to showcase themselves and the @lab_nib@UTDResearch@BBSutdallas
.@doloromics is developing novel therapeutics to treat #ChronicPain. Join us for our next #Neuroscience webinar to hear how they use #SpatialBiology to uncover low expressed drug targets that would otherwise be overlooked.
https://t.co/lFfstMrmch
Last weekend’s science experiment involved learning about acute pain in the Marin Ultra Challenge. Results: lots of pain. Discussion: when’s the next one?
To celebrate #IWD2022, SMi's Pain Therapeutics Conference welcome industry expert female speakers from leading companies to discuss research, developments & key challenges faced in the pain therapeutics field
@gbsciencesinc@NIH_NCCIH@doloromics@UniofReading
We are thrilled to share we've raised $41.5M in our Series B that will grow our team and expand our product portfolio! Thanks to Marshall Wace and @JHIAdvisors for co-leading the round. Check out the release for even more details https://t.co/pJalYFypM7 #singlecell#tech#vc